Examination of Trends in Multiple Myeloma Trial Patient Experiences

Power Life Sciences Inc.500 enrolled

Overview

Historically, participation in clinical trials has been highly skewed towards specific demographic groups. However, research identifying which trial attributes impact participation, in either positive or negative ways, is limited. This study invites participants to record a wide range of data on their clinical trial experience, with the goal being to identify factors which persistently limit patients' ability to participate in, or complete, a trial in which they were initially interested. Data will be analyzed through a range of demographic lenses, in hopes of discovering patterns which might improve the experience of future multiple myeloma patients.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Multiple Myeloma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed * Patient has been diagnosed with multiple myeloma * Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination. Exclusion Criteria: * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form * Pregnant, breastfeeding or expecting to conceive within the projected duration of the study

Outcomes

Primary Outcomes

Number of participants with multiple myeloma who decide to enroll in clinical trial